Andrzej Andraczke - Sep 21, 2023 Form 4/A - Amendment Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-fact
Stock symbol
CNSP
Transactions as of
Sep 21, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
10/12/2023, 06:00 PM
Date Of Original Report
Sep 25, 2023
Previous filing
Jul 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNSP Option to purchase common stock Award +39.5K +663.11% 45.4K Sep 21, 2023 Common Stock 39.5K $1.09 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
F2 The stock options were issued in connection with the reporting person's Board of Director services to the Company.

Remarks:

This amendment is being filed solely to correct the number of shares of common stock underlying the reported option, and total number of derivative securities owned following the reported transaction.